AVTX Avalo Therapeutics, Inc.
$6.75▼ -0.30%
Healthcare
Other
After hours
$6.75▲ +0.00%
Oct 27, 4:01 PM ET
Volume 2.64M
Avg Volume (10D) 4.29M
Key Metrics & Fundamentals
Market Cap
$362.00M
P/E Ratio
–
Div Yield
0.00%
52W Range
6.53 - 24.27
% vs 50 MA
-56.56%
% vs 200 MA
-58.27%
RSI-14
16.8
MACD Histogram
-0.5200
Beta (1Y vs SPY)
1.34
Free Cash Flow
-$19.99M
Gross Rev
$0
Gross Profit
$0
EBITDA
-$23.92M
COGS
–
Operating Exp
$31.52M
Operating Income
-$31.52M
EBIT
-$31.52M
Pretax Income
-$36.34M
Net Income
-$36.36M
EPS (Diluted)
-0.83
Price & Volume History
Loading chart…
Recent News
Sector Update: Healthcare Stocks Fall Late Afternoon
MT Newswires · Oct 23, 2026 3:56 PM ET
Sector Update: Healthcare
MT Newswires · Oct 23, 2026 3:27 PM ET
Avalo Therapeutics Shares Fall After HC Wainwright Downgrade
MT Newswires · Oct 23, 2026 3:09 PM ET
HC Wainwright Downgrades Avalo Therapeutics to Neutral From Buy
MT Newswires · Oct 23, 2026 7:09 AM ET
Guggenheim Downgrades Avalo Therapeutics to Neutral From Buy
MT Newswires · Oct 23, 2026 7:08 AM ET
AbbVie Slips Behind Rivals as Lutikizumab Hits 31.4% Response in HS Trial
TIKR · Oct 22, 2026 4:17 PM ET
Top Midday Decliners
MT Newswires · Oct 22, 2026 1:51 PM ET
Avalo Therapeutics Abdakibart Potential Intact After AbbVie Data, Wedbush Says
MT Newswires · Oct 22, 2026 12:45 PM ET
Wedbush Adjusts Avalo Therapeutics Price Target to $22 From $34, Maintains Outperform Rating
MT Newswires · Oct 22, 2026 12:21 PM ET
Avalo Therapeutics Announces Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire · Sep 29, 2026 4:01 PM ET
Financial Overview - Income Statement
Quarterly
Dec 2025
See AVTX's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.